Leslie Golden, MD, MPH, argues that policymakers in Washington must prioritize coverage of obesity treatments to ensure equitable access among US patients. Gastroenterology Advisor, a trusted source ...

Policymakers must prioritize access to innovative obesity care in tackling the obesity epidemic across the United States.

Topline data were announced from a trial evaluating zanzalintinib plus atezolizumab in adults with previously treated non-MSI-high mCRC.

Postoperative ileus rates are lower overall but remain higher across academic hospitals and those of a larger size.

Individuals with cystic fibrosis or CFTR gene variants have a 3-fold higher risk of developing pancreatic cancer after 50 years of age.

Fecal microbiota transplantation could be considered as first-line therapy for primary Clostridioides difficile infection.

For adults with obesity or overweight without diabetes, ecnoglutide yields a superior and sustained reduction in body weight vs placebo.

Type 1 diabetes risk was elevated among patients with celiac disease, hypothyroidism, or hyperthyroidism vs control patients.

Self-esteem scores increase after metabolic and bariatric surgery, with greater improvement in scores with higher postoperative weight loss.

Black patients have a higher incidence of minor complications after metabolic and bariatric surgery, according to a recent study.

People undergoing metabolic and bariatric surgery are less likely to develop psychiatric disorders than those treated with GLP-1 RAs.

Concurrent fecal incontinence and chronic constipation has its own distinct clinical and pathophysiological features.